News

18/09/2024

Dr. M. Rosa Ballester i Verneda, New Corresponding Academic at the Royal Academy of Pharmacy

On September 4th, Dr. M. Rosa Ballester i Verneda, Head of Responsible Research and Innovation (RRI) at the Sant Pau Research Institute, was inducted as a Corresponding Academic at the Royal Academy o...

13/09/2024

Discovery of a Therapeutic Pathway to Enhance the Cardioprotective Potential of HDL in People with Familial Hypercholesterolemia

A new study reveals a therapeutic pathway that could improve the cardioprotective potential of "good" cholesterol (carried by HDL) in people with familial hypercholesterolemia, a genetic disorder that...

02/09/2024

A Study by Sant Pau Reveals That Emotional State and Stress During the COVID-19 Lockdown Affected Women’s Menstrual Cycle Patterns

A recent study published by researchers from the Reproductive Health Group of the Sant Pau Research Institute (IR Sant Pau) and the Gynecology and Obstetrics Service of Sant Pau Hospital concludes tha...

20/08/2024

The Epicardial Fat of Patients with Type 2 Diabetes Exerts Negative Effects on Cardiac Cells That Are Reversed in the Presence of ApoJ

Patients with type 2 diabetes mellitus (T2DM) have a higher prevalence of cardiovascular disease, including both coronary artery disease and heart failure. Diabetic cardiomyopathy is a condition where...

13/08/2024

A Sant Pau Study Concludes that the Use of Statins Reduces the Risk of Recurrent Stroke in Patients with Cerebral Microbleeds

A study published in the journal Neurology concludes that the use of statins—drugs to lower blood cholesterol—significantly reduces the risk of recurrent stroke without increasing the risk of brai...